Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records

作者：Shaohua Lyu, Claire Shuiqing Zhang, Jingbo Sun, Heng Weng, Charlie Changli Xue, Xinfeng Guo, Anthony Lin Zhang · 发表于：Frontiers in Medicine · 年份：2022 · DOI：10.3389/fmed.2022.936234 · 被引用次数：18 · 研究领域：Migraine and Headache Studies、Biological and pharmacological studies of plants、Traditional Chinese Medicine Studies

Background Migraine is a chronic neurological disease causing significant socioeconomic burden and impaired quality of life. Chinese medicine is commonly used for migraine in China. Clinical trials have generated evidence of the effectiveness of Chinese medicine therapies for migraine. However, little is known about how to use these therapies to treat migraine in real-world clinical settings. Methods In this retrospective study, we analyzed data from the electronic medical records (EMRs) of 2,023 migraine patients who attended the Guangdong Provincial Hospital of Chinese Medicine (GPHCM) between July 2018 and July 2020. Results More than three-quarters (77.21%) of the patients were female. Most (78.20%) of the patients were aged between 18 and 50 years, 18.49% were aged above 50 years, and the remaining 3.31% were under 18 years. Sleep disorders were the most documented comorbidity occurring in 27.29% of patients, and more common in females (29.77%) than male (18.87%). Fatigue was the most frequently reported trigger of migraine attacks among all patients (9.39%), while menstruation was the most common trigger for female patients (10.24%). Less than a quarter of patients (21.01%) reported a history of taking analgesic medication for their migraine. The median treatment duration reported by the patients was 10 days. Chinese herbal medicine (CHM) was the predominant treatment for migraine at the hospital (88.48%), while pharmacotherapies were prescribed to 28.97% of the patient...